A venture-backed startup in the medical vaporizer market had developed an innovative, sophisticated device to meet growing consumer demand. While eager to manufacture in China, the client faced two major challenges:
Lack of manufacturing experience – No prior experience in navigating China’s complex supply chain.
Intellectual property (IP) concerns – Needed to protect proprietary components from potential replication.
To successfully bring their medical vaporizer to market, the client required expert guidance in supplier selection, product optimization, and IP security measures.
CMD’s cross-functional team worked closely with the client to identify, vet, and develop a manufacturing strategy that ensured high-quality production while safeguarding IP. Key deliverables included:
Supplier identification & qualification – Sourced manufacturers capable of integrating multiple disciplines, including:
IP Protection Strategy – Imported key proprietary components from the USA under CMD’s Class A import/export license, preventing unauthorized replication.
Supply Chain Optimization –
Design for Manufacturability (DFM) Collaboration –
Launched a high-quality, innovative medical vaporizer on schedule.
Protected proprietary technology while leveraging cost-efficient manufacturing in China.
Achieved cost, delivery, and quality targets, ensuring a sustainable business model.
Secured a long-term, reliable manufacturing partner, supporting future scalability.
By partnering with CMD, the client successfully transformed an idea into a market-ready product, proving that IP protection and efficient China manufacturing can go hand in hand.
Looking to manufacture in China while safeguarding your intellectual property? Contact CMD today.